Due to the involvement of HLA-DRB5 in the processing and presentation of inflammatory and immune-related antigens processing and presentation [71, 72], HLA-DRB5 may have a predictive value for survival rates of patients with malignant tumors [73]. Here, HLA-DRB5 is linked to cancer.